Technology Areas

Practice Areas


  • Patent Agent, U.S. Patent and Trademark Office, 2001


University of Wisconsin, Ph.D., Physical Chemistry, 1982

Bucknell University, B.S., Chemistry, magna cum laude, 1975

Photo of Sandra L. Shaner, Ph.D.

Sandra L. Shaner, Ph.D.

Senior Patent Agent

Sandra Shaner concentrates her practice primarily in the areas of biotechnology, pharmaceuticals, food science, and material science. She has extensive experience in patent application, preparation, and prosecution and patent searching. Sandy has prepared and prosecuted patent applications involving pharmaceutical compositions and formulations, medical treatments, biologics, immunotherapy, antibody technology, gene therapy, nucleic acid and amino acid sequences, and pharmacogenomics. She has experience preparing patentability opinions and patent landscape reports, and has also been involved in opinion and due diligence work relating to pharmaceuticals, biologics, and diagnostics.

Experience Highlights

Senior Patent Agent, Cantor Colburn LLP, 2016-present

Patent Agent, Cantor Colburn LLP, 2004-2015

Senior Patent Agent, Genaissance Pharmaceuticals, Inc., New Haven, CT, 2000-2004

Principal, SLS Consulting, New Haven, CT, 1999-2000

  • Consultant in biophysical chemistry, experimental design and analysis, writing and editing

Assistant Professor, Department of Biochemistry, Wayne State University, in Detroit, MI, 1990-1997

Associate Research Scientist, Yale University, New Haven, CT, Department of Human Genetics, 1982-1990

Representative Matters

  • U.S. 7,122,566  Metaxalone products, method of manufacture and method of use
  • US 6,944,767   Methods and apparatus for ensuring the privacy and security of personal  medical information
  • US 6,929,912   Methods for evaluating the ability to metabolize pharmaceuticals
  • US 6,797,477   Genetic typing of the human cytochrome P450 2A6 gene and related methods
  • US 6,521,747   Haplotypes of the AGTR1 gene
  • WO200504801 Methods For Haplotype Assignment
  • WO2004033710 ITGB3 Gene Haplotypes And Atorvastatin Dose Effects On HDL Cholesterol
  • WO2004003167 GUCY1B2 Genetic Markers For LDL Cholesterol Response To Statin Therapy




Professional Affiliations

American Association for the Advancement of Science

American Chemical Society

Intellectual Property Owners Association